Epic Sciences
10975 N. Torrey Pines Road
La Jolla
California
92037
United States
Website: http://www.epicsciences.com/
Email: info@epicsciences.com
85 articles about Epic Sciences
-
San Diego's Epic Sciences Rakes in $40 Million Series D
4/28/2017
-
Meet SoCal's Epic Sciences, One Of The Coolest Kids In Biopharma Right Now
4/28/2017
-
Study From Memorial Sloan-Kettering Cancer Center And Epic Sciences Shows Only Nuclear-Localized AR-V7 Is Predictive Of Therapy Benefit For Patients With Metastatic Prostate Cancer
1/6/2017
-
Epic Sciences Validates Single CTC Sequencing, Identifies Clonal Heterogeneity In Metastatic Cancer
11/17/2016
-
Genomic Health, Inc. And Epic Sciences Announce Strategic Collaboration To Deliver Novel AR-V7 Liquid Biopsy Test To Predict Treatment Response In Metastatic Prostate Cancer
7/7/2016
-
Epic Sciences Introduces Sensitive HRD Liquid Biopsy Test for PARP Inhibitor Clinical Trials
6/24/2016
-
Presence Of AR-V7 In Circulating Tumor Cells Validated As Predictive Biomarker For Advanced Prostate Cancer Treatment By Memorial Sloan-Kettering Cancer Center And Epic Sciences
6/6/2016
-
Epic Sciences To Present At Molecular Medicine Tri-Con 2016
3/4/2016
-
Avera Medical Group And Epic Sciences Collaborate On Cancer Precision Medicine Clinical Trials
1/28/2016
-
Epic Sciences Receives CAP Accreditation
1/11/2016
-
Epic Sciences Release: Circulating Tumor Cells Linked With Treatment Resistance And Response In Prostate Cancer Patients
1/5/2016
-
Epic Sciences Enters Into 35th Pharma Collaboration To Advance Companion Diagnostics For New Targeted Therapeutics
12/11/2015
-
Epic Sciences' Chief Scientific Officer Named Leading Global Thinker By Foreign Policy Magazine
12/1/2015
-
Epic Sciences Partners With University of Pennsylvania's Abramson Cancer Center On Cancer Therapy Discoveries Through Liquid Biopsy
11/13/2015
-
Circulating Tumor Cells (CTCs) In Patients' Blood Detected By Epic Sciences Are An "Accurate Representation" Of Genetic Aberrations Found In Fresh Metastatic Tumor Samples
11/11/2015
-
Epic Sciences Platform Capable Of Single Cell CTC Identification Sequencing In Late Stage, Metastatic Cancer
11/2/2015
-
Epic Sciences To Present At World CDx Boston 2015
9/2/2015
-
Epic Sciences Appoints Dave Henderson As Chief Information Officer
8/26/2015
-
Epic Sciences' Dr. Dena Marrinucci Is Recognized As An Honoree Of MIT Technology Review's Annual INNOVATORS UNDER 35 List
8/18/2015
-
Epic Sciences Publication Validates Unbiased Detection Of Circulating Tumor Cells (CTCs) From A Liquid Biopsy
8/11/2015